Clarivate Releases Top 100 Global Innovators 2022 List
Clarivate Plc has released the Top 100 Global Innovators™ 2022 list. Drawing on Clarivate™ data, the annual list identifies the organizations that demonstrate consistent, above-the-bar innovation excellence and which sit at the very top of the global innovation ecosystem.
As it relates to pharma and medtech, three companies in those industries have been identified in this year’s top 100 list, including:
- Johnson & Johnson- United States- Pharmaceuticals (2nd consecutive year featured as a top 100 Global innovator)
- Philips- Netherlands- Medical and biotechnology (2nd consecutive year featured as a top 100 Global innovator)
- Roche- Switzerland- Pharmaceuticals (11th consecutive year featured as a top 100 Global innovator)
The pharmaceuticals sector remains represented in the Top 100 Global Innovators 2022, but perhaps at a lower level than in previous years. This sector’s success in delivering vast improvement in human health, highlighted so importantly during the last 2 years, is partially due to the very high level of collaboration and partnership the sector has evolved into over the past two decades.
Read more about the full report here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
